Abstract:Emergency department (ED) visits among persons living with dementia represent a substantial health care challenge, often necessitating targeted interventions to optimize care and support. 1 Previous studies have primarily focused on health care use outcomes after formal diagnosis or during end-of-life periods for individuals with dementia. 2 ,3 We assessed changes in ED use before and after incident dementia diagnosis among Medicare beneficiaries aged 65 years and older. This cohort study used data from the Medicare Current Beneficiary Survey from 2015 to 2021 and included beneficiaries with an incident diagnosis of dementia (ie, cases) and a 1:2 propensity score–matched (for age, sex, race and ethnicity, and chronic conditions) population without a dementia diagnosis (ie, comparators). We identified cases from inpatient or outpatient claims with a diagnosis of dementia ( International Statistical Classification of Diseases, Tenth Revision codes F01, F02, F03, and G30). The Yale University Institutional Review Board waived the need for approval and informed consent owing to the use of publicly available data. We followed the STROBE reporting guideline. The primary outcome was the rate of monthly ED visits for cases and comparators in the 6 months before and 6 months after the date that case patients were diagnosed with dementia. If a dementia diagnosis was received on the same date as an ED visit, we classified these patients as having the visit before the diagnosis. We calculated descriptive statistics and estimated a zero-inflated negative binomial regression model, including adjustments for key beneficiary sociodemographic and health status characteristics. Self-reported race and ethnicity data were collected because these variables are associated with disparities in health care access and use. Statistical analyses were conducted at the beneficiary level using R, version 4.0.2 (R Project for Statistical Computing) and were performed October 1, 2023, through June 30, 2024. Two-sided t tests or Pearson χ 2 tests established statistical significance at P < .05. Our sample included 1779 Medicare beneficiaries with incident dementia and 3558 matched comparators without dementia, reflecting 17 919 504 Medicare beneficiaries after applying survey weights. Among patients with an incident dementia diagnosis, the mean (SD) age at the time of diagnosis was 82.0 (7.6) years; 1060 patients (59.6%) were women and 719 (40.4%) were men. The patient characteristic percentages for patients with a dementia diagnosis were similar to those for patients without a diagnosis (Table). In the sixth month before a diagnosis of dementia, the ED visit rate was 1.69 out of 100 beneficiaries vs 2.08 out of 100 beneficiaries for those without a diagnosis. In the month immediately preceding a diagnosis of dementia, the ED visit rate was 13.0 out of 100 beneficiaries vs 2.95 out of 100 beneficiaries for those without a diagnosis. In the month immediately subsequent to a diagnosis of dementia, the ED visit rate was 3.32 out of 100 beneficiaries vs 2.73 out of 100 beneficiaries for those without a diagnosis (Figure, A). Within the entirety of the 12-month period assessed, having a diagnosis of dementia was associated with a 40% increase in the likelihood of having an ED visit (odds ratio, 1.40 [95% CI, 1.25-1.58]; P < .001) (Figure, B). The observed changes in ED use, with peaks before and after dementia diagnosis, suggest that the diagnostic process may precipitate acute health care crises and increased health care–seeking behavior among individuals with dementia and their caregivers. Additionally, ED visits may trigger a diagnostic cascade toward dementia, reflecting the complex nature of dementia identification and management. Often a crucial contact point, the ED setting provides a valuable opportunity to screen for cognitive impairment, 4 -6 which might otherwise go unnoticed until it has progressed substantially. A limitation of this study is that the generalizability of our findings may not extend beyond Medicare beneficiaries. Additionally, claims-based dementia diagnoses may not capture milder forms of cognitive impairment. Future longitudinal and qualitative studies are needed to elucidate the complex associations between dementia progression, comorbidities, and health care use. Accepted for Publication: August 22, 2024. Published: October 14, 2024. doi:10.1001/jamanetworkopen.2024.39421 Open Access: This is an open access article distributed under the terms of the CC-BY License. © 2024 Gettel CJ et al. JAMA Network Open . Corresponding Author: Cameron J. Gettel, MD, MHS, Department of Emergency Medicine, Yale School of Medicine, 464 Congress St, Ste 260, New Haven, CT 06519 (cameron.gettel@yale.edu). Author -Abstract Truncated-

DMV Reporting Mandates of Dementia Diagnoses and Dementia Underdiagnosis

A comparison of dementia diagnoses and cognitive function measures in Medicare claims and the Minimum Data Set

Potentially Unsafe Activities and Living Conditions of Older Adults with Dementia

Identifying Dementia Severity Among People Living With Dementia Using Administrative Claims Data

ED Visits Among Patients With Dementia Before and After Diagnosis

Differences in setting of initial dementia diagnosis among fee‐for‐service Medicare beneficiaries

Use of the Dementia Assessment Sheet for Community‐based Integrated Care System 21 Items among Chinese Community‐dwelling Older Adults

Receipt of Eye Care Services among Medicare Beneficiaries with and without Dementia

It Is Time for Medicare to Cover Driving Safety Assessments

Association of Autoimmune Disorders and Disease-modifying Antirheumatic Drugs: (DMARDs) with the Risk of Alzheimer's and/or Dementia: A Population Study Using Medicare Beneficiary Data

Prevalence Estimation of Dementia/Alzheimer's Disease Using Health and Retirement Study Database in the United States

A Systematic Review on the Evidence of Misdiagnosis in Dementia and Its Impact on Accessing Dementia Care

Drivers of Memory Loss Underreport in Mild Cognitive Impairment Due to Alzheimer Versus Vascular Disease

Diagnoses and Treatment of Behavioral and Psychological Symptoms of Dementia Among Racially and Ethnically Diverse Persons Living with Dementia

Mandarin version of dementia and driving decision aid (DDDA): Development and stakeholder evaluation in Taiwan

Demographics, comorbidities, and comedications in newly diagnosed patients with Alzheimer's disease and related dementias: Findings from United States Medicare claims data

A Mixed-Methods Study of the Impact of Mild Cognitive Impairment Diagnosis on Patient and Care Partner Perception of Health Risks

Association of the Area Deprivation Index With Dementia Basic Workup and Diagnosis in Central and Western Virginia: A Cross-Sectional Study

Under-Diagnosis of Dementia with Lewy Bodies in Individuals Racialized as Black: Hypotheses Regarding Potential Contributors

Prevalence of Mild Cognitive Impairment and Alzheimer's Disease Identified in Veterans in the United States

The Long-Term Impacts of Dementia on Preventive Care Utilization and Health Behaviors